We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HERO
851
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
– –
-10,030
Closed -$46K
TXTR
852
DELISTED
TEXTURA CORPORATION COM
TXTR
– –
-22,946
Closed -$578K
HPY
853
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
– –
-12,748
Closed -$528K
ARO
854
DELISTED
Aeropostale Inc
ARO
– –
-12,964
Closed -$65K
HCBK
855
DELISTED
HUDSON CITY BANCORP INC
HCBK
– –
-16,032
Closed -$158K
THOR
856
DELISTED
THORATEC CORPORATION
THOR
– –
-5,710
Closed -$204K
HSP
857
DELISTED
HOSPIRA INC
HSP
– –
-5,170
Closed -$224K
RCPT
858
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-6,015
Closed -$252K
ZEP
859
DELISTED
ZEP INC COM STK (DE)
ZEP
– –
-10,047
Closed -$178K
TRW
860
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
– –
-2,910
Closed -$238K
MWIV
861
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
– –
-1,340
Closed -$209K
SWY
862
DELISTED
SAFEWAY INC
SWY
– –
-7,316
Closed -$242K
STSI
863
DELISTED
STAR SCIENTIFIC INC
STSI
– –
-13,109
Closed -$10K
BRE
864
DELISTED
BRE PROPERTIES INC CL A
BRE
– –
-24,200
Closed -$1.52M
CTIC
865
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-1,140
Closed -$39K
COV
866
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-8,900
Closed -$656K
CA
867
DELISTED
CA, Inc.
CA
– –
-7,980
Closed -$247K
VVUS
868
DELISTED
Vivus Inc
VVUS
– –
-1,299
Closed -$77K
GG
869
DELISTED
Goldcorp Inc
GG
– –
-15,542
Closed -$380K
OSIR
870
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
– –
-10,757
Closed -$141K
SPLS
871
DELISTED
Staples Inc
SPLS
– –
-19,410
Closed -$220K
VG
872
DELISTED
Vonage Holdings Corporation
VG
– –
-11,210
Closed -$48K
NIHD
873
DELISTED
NII HOLDINGS INC CL B
NIHD
– –
-10,100
Closed -$12K
31 32 33 34
35

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.